Antitumour Effects of Salvia Miltiorrhiza based on the Theory of Homology of Food and Medicine
DOI:
https://doi.org/10.53469/jcmp.2024.06(07).45Keywords:
Salvia miltiorrhiza, Cancer, Tumour, Medicinal herbsAbstract
Salvia miltiorrhiza Bunge is a plant of the family Labiatae, which is of great value in traditional Chinese medicine. Salvia miltiorrhiza Bunge has a slight odour, slightly bitter and astringent taste. It is slightly cold. Salvia miltiorrhiza belongs to the heart and liver meridians. It has the functions of activating blood circulation, removing blood stasis, promoting menstruation, relieving pain, Clear and reduce stagnant heat, cooling blood and eliminating carbuncles. It is used in the treatment of chest paralysis and heart pain, epigastric and abdominal pain, accumulation of obstruction in the abdomen, insomnia, irregular menstruation, sores, swelling and pain, cancer, etc. It has high medicinal health value and has been listed as one of the most important medicinal drugs in the world. It is of high medicinal and health care value, and has been listed in the catalogue of medicinal dietary sources in China, which has a broad space for development and application. The purpose of this paper is to review the research progress of Salvia miltiorrhiza in processing methods and antitumour activity, and to elaborate the performance of Salvia miltiorrhiza in ancient and modern clinical applications by giving examples, with a view to providing reference and contribution to the in-depth research, clinical application and development of Salvia miltiorrhiza. The sources, functions and dosage forms of Salvia miltiorrhiza were comprehensively analysed through the analysis of traditional Chinese patent medicines, simple preparations and related health food products of Salvia miltiorrhiza queried by Yaozhi.com, with a view to providing references for the development of Salvia miltiorrhiza medicines and food products.
References
Bae, W. J., J. B. Choi, K. S. Kim, U. S. Ha, S. H. Hong, J. Y. Lee, T. K. Hwang, S. Y. Hwang, Z. P. Wang, and S. W. Kim. 2020. 'Inhibition of Proliferation of Prostate Cancer Cell Line DU-145 in vitro and in vivo Using Salvia miltiorrhiza Bunge', Chin J Integr Med, 26: 533-38.
Chen, B., C. Huang, Y. Zhang, X. Tang, S. Li, Q. Wang, and Y. Lin. 2020. 'Salvia bowleyana Dunn root is a novel source of salvianolic acid B and displays antitumor effects against gastric cancer cells', Oncol Lett, 20: 817-27.
Chen, Y., H. Li, M. Li, S. Niu, J. Wang, H. Shao, T. Li, and H. Wang. 2017. 'Salvia miltiorrhiza polysaccharide activates T Lymphocytes of cancer patients through activation of TLRs mediated -MAPK and -NF-κB signaling pathways', J Ethnopharmacol, 200: 165-73.
Chen, Z., X. Gao, Y. Jiao, Y. Qiu, A. Wang, M. Yu, F. Che, S. Li, J. Liu, J. Li, H. Zhang, C. Yu, G. Li, Y. Gao, L. Pan, W. Sun, J. Guo, B. Cao, Y. Zhu, and H. Xu. 2019. 'Tanshinone IIA Exerts Anti-Inflammatory and Immune-Regulating Effects on Vulnerable Atherosclerotic Plaque Partially via the TLR4/MyD88/NF-κB Signal Pathway', Front Pharmacol, 10: 850.
Chiu, S. C., S. Y. Huang, S. P. Chen, C. C. Su, T. L. Chiu, and C. Y. Pang. 2013. 'Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo', Prostate Cancer Prostatic Dis, 16: 315-22.
Chiu, T. L., and C. C. Su. 2017. 'Tanshinone IIA increases protein expression levels of PERK, ATF6, IRE1α, CHOP, caspase‑3 and caspase‑12 in pancreatic cancer BxPC‑3 cell‑derived xenograft tumors', Mol Med Rep, 15: 3259-63.
Chuang, C. Y., Y. C. Ho, C. W. Lin, W. E. Yang, Y. L. Yu, M. C. Tsai, S. F. Yang, and S. C. Su. 2020. 'Salvianolic acid A suppresses MMP-2 expression and restrains cancer cell invasion through ERK signaling in human nasopharyngeal carcinoma', J Ethnopharmacol, 252: 112601.
Cui, S., T. Chen, M. Wang, Y. Chen, Q. Zheng, X. Feng, S. Li, and J. Wang. 2022. 'Tanshinone I inhibits metastasis of cervical cancer cells by inducing BNIP3/NIX-mediated mitophagy and reprogramming mitochondrial metabolism', Phytomedicine, 98: 153958.
Dalil, D., S. Iranzadeh, and S. Kohansal. 2022. 'Anticancer potential of cryptotanshinone on breast cancer treatment; A narrative review', Front Pharmacol, 13: 979634.
Deng, R., X. Ren, D. Liu, Z. Lu, and P. Liu. 2024. 'An Evaluation of the Edible Value of Salvia miltiorrhiza Seeds: Proximate Composition, Phytochemical Components and Antioxidant Activity. LID - 10.3390/molecules29071483 [doi] LID - 1483', Molecules
Ding, L., S. Wang, X. Qu, and J. Wang. 2016. 'Tanshinone IIA sensitizes oral squamous cell carcinoma to radiation due to an enhanced autophagy', Environ Toxicol Pharmacol, 46: 264-69.
Fu, Y. P., X. Peng, C. W. Zhang, Q. X. Jiang, C. Y. Li, B. S. Paulsen, F. Rise, C. Huang, B. Feng, L. X. Li, X. F. Chen, R. Y. Jia, Y. P. Li, X. H. Zhao, G. Ye, H. Q. Tang, X. X. Liang, C. Lv, M. L. Tian, Z. Q. Yin, and Y. F. Zou. 2023. 'Salvia miltiorrhiza polysaccharide and its related metabolite 5-methoxyindole-3-carboxaldehyde ameliorate experimental colitis by regulating Nrf2/Keap1 signaling pathway', Carbohydr Polym, 306: 120626.
Gong, L., C. Di, X. Xia, J. Wang, G. Chen, J. Shi, P. Chen, H. Xu, and W. Zhang. 2016. 'AKT/mTOR signaling pathway is involved in salvianolic acid B-induced autophagy and apoptosis in hepatocellular carcinoma cells', Int J Oncol, 49: 2538-48.
Guan, Z., J. Chen, X. Li, and N. Dong. 2020. 'Tanshinone IIA induces ferroptosis in gastric cancer cells through p53-mediated SLC7A11 down-regulation', Biosci Rep, 40.
Guo, P., S. Wang, W. Liang, W. Wang, H. Wang, M. Zhao, and X. Liu. 2017. 'Salvianolic acid B reverses multidrug resistance in HCT‑8/VCR human colorectal cancer cells by increasing ROS levels', Mol Med Rep, 15: 724-30.
Hou, X., C. Zhou, Z. Liang, H. Qiu, Z. Zhou, H. Zheng, Z. Li, Y. Wang, X. Qi, L. Lu, Y. Cao, and J. Zheng. 2023. 'Salvianolic acid F suppresses KRAS-dependent lung cancer cell growth through the PI3K/AKT signaling pathway', Phytomedicine, 121: 155093.
Huang, Y., S. H. Yu, W. X. Zhen, T. Cheng, D. Wang, J. B. Lin, Y. H. Wu, Y. F. Wang, Y. Chen, L. P. Shu, Y. Wang, X. J. Sun, Y. Zhou, F. Yang, C. H. Hsu, and P. F. Xu. 2021. 'Tanshinone I, a new EZH2 inhibitor restricts normal and malignant hematopoiesis through upregulation of MMP9 and ABCG2', Theranostics, 11: 6891-904.
Jiang, G., J. Liu, B. Ren, L. Zhang, L. Owusu, L. Liu, J. Zhang, Y. Tang, and W. Li. 2017. 'Anti-tumor and chemosensitization effects of Cryptotanshinone extracted from Salvia miltiorrhiza Bge. on ovarian cancer cells in vitro', J Ethnopharmacol, 205: 33-40.
Jing, Y., J. Hu, Z. Su, W. Cheng, Y. Zhang, X. Yang, D. Zhang, and L. Wu. 2023. 'Structural characterisation and antioxidant activities in vitro and in vivo of a novel polysaccharide from Salvia miltiorrhiza', Nat Prod Res, 37: 1006-11.
Jung, I., H. Kim, S. Moon, H. Lee, and B. Kim. 2020. 'Overview of Salvia miltiorrhiza as a Potential Therapeutic Agent for Various Diseases: An Update on Efficacy and Mechanisms of Action', Antioxidants (Basel), 9.
Katary, M. A., R. Abdelsayed, A. Alhashim, M. Abdelhasib, and A. A. Elmarakby. 2019. 'Salvianolic Acid B Slows the Progression of Breast Cancer Cell Growth via Enhancement of Apoptosis and Reduction of Oxidative Stress, Inflammation, and Angiogenesis', Int J Mol Sci, 20.
Lee, G. Y., J. S. Lee, C. G. Son, and N. H. Lee. 2021. 'Combating Drug Resistance in Colorectal Cancer Using Herbal Medicines', Chin J Integr Med, 27: 551-60.
Leng, X., H. Kan, Q. Wu, C. Li, Y. Zheng, and G. Peng. 2022. 'Inhibitory Effect of Salvia miltiorrhiza Extract and Its Active Components on Cervical Intraepithelial Neoplastic Cells', Molecules, 27.
LI Hang, and et al. 2019. 'Mechanism of Compound Danshen Dropping Pills Targeting JAK2/STAT3 Pathway in Inhibiting Ovarian Cancer Rats', Chinese Journal of Traditional Chinese Medicine, 37: 2269-71+319.
Li, Q., J. Zhang, Y. Liang, W. Mu, X. Hou, X. Ma, and Q. Cao. 2018. 'Tanshinone l exhibits anticancer effects in human endometrial carcinoma HEC-1-A cells via mitochondrial mediated apoptosis, cell cycle arrest and inhibition of JAK/STAT signalling pathway', J buon, 23: 1092-96.
Li, Y., X. Zhang, Y. Li, P. Yang, Z. Zhang, H. Wu, L. Zhu, and Y. Liu. 2023. 'Preparation methods, structural characteristics, and biological activity of polysaccharides from Salvia miltiorrhiza: A review', J Ethnopharmacol, 305: 116090.
Li, Z., J. Zou, D. Cao, and X. Ma. 2020. 'Pharmacological basis of tanshinone and new insights into tanshinone as a multitarget natural product for multifaceted diseases', Biomed Pharmacother, 130: 110599.
Liang, D., S. Tang, L. Liu, M. Zhao, X. Ma, Y. Zhao, C. Shen, Q. Liu, J. Tang, J. Zeng, and N. Chen. 2023. 'Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway', Int Immunopharmacol, 124: 110902.
Luo, L., J. Xue, Z. Shao, Z. Zhou, W. Tang, J. Liu, H. Hu, and F. Yang. 2023. 'Recent developments in Salvia miltiorrhiza polysaccharides: Isolation, purification, structural characteristics and biological activities', Front Pharmacol, 14: 1139201.
Mei, X., H. Zhao, Y. Huang, Y. Tang, X. Shi, W. Pu, S. Jiang, Y. Ma, Y. Zhang, L. Bai, W. Tu, Y. Zhao, L. Jin, W. Wu, J. Wang, and Q. Liu. 2020. 'Involvement of Disabled-2 on skin fibrosis in systemic sclerosis', J Dermatol Sci, 99: 44-52.
Nagappan, A., J. H. Kim, D. Y. Jung, and M. H. Jung. 2019. 'Cryptotanshinone from the Salvia miltiorrhiza Bunge Attenuates Ethanol-Induced Liver Injury by Activation of AMPK/SIRT1 and Nrf2 Signaling Pathways', Int J Mol Sci, 21.
Nie, Z. Y., M. H. Zhao, B. Q. Cheng, R. F. Pan, T. R. Wang, Y. Qin, and X. J. Zhang. 2020. 'Tanshinone IIA regulates human AML cell proliferation, cell cycle, and apoptosis through miR-497-5p/AKT3 axis', Cancer Cell Int, 20: 379.
Nițescu, D. A., A. Mușetescu, M. Nițescu, M. Costescu, and O. A. Coman. 2021. 'Experimental research in topical psoriasis therapy (Review)', Exp Ther Med, 22: 971.
QIAO Lili, HU Tong, Lv Ping, and et al. 2023. 'Effect of Qingre Jiedu Xiaozheng Decoction Combined with Rescue Treatment on Clinical Efficacy,Tumor Markers and TCM Syndrome Score of Patients with Advanced Breast Cancer', Chinese Journal of Traditional Chinese Medicine, 41: 214-17.
Qin, J., H. Shi, Y. Xu, F. Zhao, and Q. Wang. 2018. 'Tanshinone IIA inhibits cervix carcinoma stem cells migration and invasion via inhibiting YAP transcriptional activity', Biomed Pharmacother, 105: 758-65.
Ru, J., P. Li, J. Wang, W. Zhou, B. Li, C. Huang, P. Li, Z. Guo, W. Tao, Y. Yang, X. Xu, Y. Li, Y. Wang, and L. Yang. 2014. 'TCMSP: a database of systems pharmacology for drug discovery from herbal medicines', J Cheminform, 6: 13.
Shi, M., F. Huang, C. Deng, Y. Wang, and G. Kai. 2019. 'Bioactivities, biosynthesis and biotechnological production of phenolic acids in Salvia miltiorrhiza', Crit Rev Food Sci Nutr, 59: 953-64.
Song, M., C. Qian, T. Zhang, Y. Tang, Y. Zhou, Z. Wei, A. Wang, C. Zhong, Y. Zhao, and Y. Lu. 2023. 'Salvia mitiorrhiza Bunge aqueous extract attenuates infiltration of tumor-associated macrophages and potentiates anti-PD-L1 immunotherapy in colorectal cancer through modulating Cox2/PGE2 cascade', J Ethnopharmacol, 316: 116735.
Su, C. C. 2018. 'Tanshinone IIA can inhibit MiaPaCa‑2 human pancreatic cancer cells by dual blockade of the Ras/Raf/MEK/ERK and PI3K/AKT/mTOR pathways', Oncol Rep, 40: 3102-11.
Sun, C., B. Han, Y. Zhai, H. Zhao, X. Li, J. Qian, X. Hao, Q. Liu, J. Shen, and G. Kai. 2022. 'Dihydrotanshinone I inhibits ovarian tumor growth by activating oxidative stress through Keap1-mediated Nrf2 ubiquitination degradation', Free Radic Biol Med, 180: 220-35.
Sung, H., J. Ferlay, R. L. Siegel, M. Laversanne, I. Soerjomataram, A. Jemal, and F. Bray. 2021. 'Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries', CA Cancer J Clin, 71: 209-49.
TIAN H, and et al. 2023. 'Danshen Injection Inhibits Platelets-induced Metastasis of Breast Cancer Cells In Vitro', Chinese Journal of Experimental Traditional Medical Formulae: 79-85.
Tu, Y., S. Qiu, Z. Y. Dong, Y. Xiao, M. Q. Huang, M. Sun, and L. N. Sun. 2021. '[Historical evolution of Salviae Miltiorrhizae Radix et Rhizoma processing methods]', Zhongguo Zhong Yao Za Zhi, 46: 4683-88.
Wang, B., F. Zou, G. Xin, B. L. Xiang, J. Q. Zhao, S. F. Yuan, X. L. Zhang, and Z. H. Zhang. 2023. 'Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874/eEF-2K/TG2 axis', Pharm Biol, 61: 868-77.
Wang, W. H., K. Y. Hsuan, L. Y. Chu, C. Y. Lee, Y. C. Tyan, Z. S. Chen, and W. C. Tsai. 2017. 'Anticancer Effects of Salvia miltiorrhiza Alcohol Extract on Oral Squamous Carcinoma Cells', Evid Based Complement Alternat Med, 2017: 5364010.
Wang, X., A. Gao, Y. Jiao, Y. Zhao, and X. Yang. 2018. 'Antitumor effect and molecular mechanism of antioxidant polysaccharides from Salvia miltiorrhiza Bunge in human colorectal carcinoma LoVo cells', Int J Biol Macromol, 108: 625-34.
Wang, Y., W. Jin, and J. Wang. 2021. 'Tanshinone IIA regulates microRNA‑125b/foxp3/caspase‑1 signaling and inhibits cell viability of nasopharyngeal carcinoma', Mol Med Rep, 23.
Won, S. H., H. J. Lee, S. J. Jeong, H. J. Lee, E. O. Lee, D. B. Jung, J. M. Shin, T. R. Kwon, S. M. Yun, M. H. Lee, S. H. Choi, J. Lü, and S. H. Kim. 2010. 'Tanshinone IIA induces mitochondria dependent apoptosis in prostate cancer cells in association with an inhibition of phosphoinositide 3-kinase/AKT pathway', Biol Pharm Bull, 33: 1828-34.
Wu, C., W. Chen, M. Fang, A. Boye, X. Tao, Y. Xu, S. Hou, and Y. Yang. 2019. 'Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation', J Ethnopharmacol, 231: 98-112.
Wu, C. F., C. Hong, S. M. Klauck, Y. L. Lin, and T. Efferth. 2015. 'Molecular mechanisms of rosmarinic acid from Salvia miltiorrhiza in acute lymphoblastic leukemia cells', J Ethnopharmacol, 176: 55-68.
Wu, C. Y., Y. H. Yang, Y. S. Lin, L. H. Shu, H. T. Liu, Y. H. Wu, and Y. H. Wu. 2023. 'Induction of ferroptosis and apoptosis in endometrial cancer cells by dihydroisotanshinone I', Heliyon, 9: e21652.
Wu, C. Y., Y. H. Yang, Y. Y. Lin, F. C. Kuan, Y. S. Lin, W. Y. Lin, M. Y. Tsai, J. J. Yang, Y. C. Cheng, L. H. Shu, M. C. Lu, Y. J. Chen, K. D. Lee, and H. Y. Kang. 2017. 'Anti-cancer effect of danshen and dihydroisotanshinone I on prostate cancer: targeting the crosstalk between macrophages and cancer cells via inhibition of the STAT3/CCL2 signaling pathway', Oncotarget, 8: 40246-63.
Wu, Q., Y. B. Guan, K. J. Zhang, L. Li, and Y. Zhou. 2023. 'Tanshinone IIA mediates protection from diabetes kidney disease by inhibiting oxidative stress induced pyroptosis', J Ethnopharmacol, 316: 116667.
Xia, M., Y. Wu, H. Zhu, and W. Duan. 2023. 'Tanshinone I induces ferroptosis in gastric cancer cells via the KDM4D/p53 pathway', Hum Exp Toxicol, 42: 9603271231216963.
Xu, H., N. N. Guo, C. Y. Zhu, L. Y. Ye, X. Y. Yan, Y. Q. Liu, Z. Y. Zhang, G. Zhang, and L. Hussain. 2024. 'Diterpenoid Tanshinones Can Inhibit Lung Cancer Progression by Improving the Tumor Microenvironment and Downregulation of NF-κB Expression', ACS Omega, 9: 7230-38.
Xu, X., W. Zhang, C. Huang, Y. Li, H. Yu, Y. Wang, J. Duan, and Y. Ling. 2012. 'A novel chemometric method for the prediction of human oral bioavailability', Int J Mol Sci, 13: 6964-82.
Ye, T., D. Xiong, L. Chen, Y. Li, S. Gong, L. Zhang, B. Li, J. Pan, J. Qian, and H. Qu. 2020. 'Effect of Danshen on TLR2-triggered inflammation in macrophages', Phytomedicine, 70: 153228.
Ye, Y. T., W. Zhong, P. Sun, D. Wang, C. Wang, L. M. Hu, and J. Q. Qian. 2017. 'Apoptosis induced by the methanol extract of Salvia miltiorrhiza Bunge in non-small cell lung cancer through PTEN-mediated inhibition of PI3K/Akt pathway', Journal of ethnopharmacology.
Yu, J. R., Y. Y. Liu, Y. Y. Gao, L. H. Qian, J. L. Qiu, P. P. Wang, and G. J. Zhang. 2024. 'Diterpenoid tanshinones inhibit gastric cancer angiogenesis through the PI3K/Akt/mTOR signaling pathway', J Ethnopharmacol, 324: 117791.
Zhang, W., C. Liu, J. Li, Y. Lu, H. Li, J. Zhuang, X. Ren, M. Wang, and C. Sun. 2022. 'Tanshinone IIA: New Perspective on the Anti-Tumor Mechanism of A Traditional Natural Medicine', Am J Chin Med, 50: 209-39.
Zhang, W., M. Liu, Y. Ji, D. Yu, C. Ma, J. Zhao, and P. Qu. 2023. 'Tanshinone IIA inhibits endometrial carcinoma growth through the MAPK/ERK/TRIB3 pathway', Arch Biochem Biophys, 743: 109655.
Zhang, Y., Y. Zhao, J. Liu, C. Li, Y. Feng, S. Jiang, X. Sun, X. Hu, and Y. Wang. 2022. 'Transgelin-2 Involves in the Apoptosis of Colorectal Cancer Cells Induced by Tanshinone-IIA', Anal Cell Pathol (Amst), 2022: 9358583.
Zhao, G., Y. Ren, J. Yan, T. Zhang, P. Lu, J. Lei, H. Rao, X. Kang, Z. Cao, F. Peng, C. Peng, C. Rao, and Y. Li. 2023. 'Neoprzewaquinone A Inhibits Breast Cancer Cell Migration and Promotes Smooth Muscle Relaxation by Targeting PIM1 to Block ROCK2/STAT3 Pathway', Int J Mol Sci, 24.
Zhao, H., Y. Liang, C. Sun, Y. Zhai, X. Li, M. Jiang, R. Yang, X. Li, Q. Shu, G. Kai, and B. Han. 2022. 'Dihydrotanshinone I Inhibits the Lung Metastasis of Breast Cancer by Suppressing Neutrophil Extracellular Traps Formation', Int J Mol Sci, 23.
Zhou, J., Y. Y. Jiang, H. Chen, Y. C. Wu, and L. Zhang. 2020. 'Tanshinone I attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of PI3K/AKT/mTOR pathway', Cell Prolif, 53: e12739.
Zhu, J., H. Chen, Y. Le, J. Guo, Z. Liu, X. Dou, and D. Lu. 2022. 'Salvianolic acid A regulates pyroptosis of endothelial cells via directly targeting PKM2 and ameliorates diabetic atherosclerosis', Front Pharmacol, 13: 1009229.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Jingxue Bai, Genping Lei, Ting Wang, Sheng Dong, Yingying Sun, Huijie Fu, Xian Lu, Dong Yang, Duo Deng
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
